Cargando…
Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowled...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733284/ https://www.ncbi.nlm.nih.gov/pubmed/35065886 http://dx.doi.org/10.1016/j.japh.2022.01.001 |
_version_ | 1784627769422905344 |
---|---|
author | Carmosino, Elizabeth Ruisinger, Janelle F. Kinsey, Joshua Davis Melton, Brittany L. |
author_facet | Carmosino, Elizabeth Ruisinger, Janelle F. Kinsey, Joshua Davis Melton, Brittany L. |
author_sort | Carmosino, Elizabeth |
collection | PubMed |
description | BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowledge of vaccine approval processes relates to vaccination intentions. OBJECTIVES: The objectives of this study were to (1) evaluate participants’ knowledge regarding COVID-19 and vaccine approval processes, (2) evaluate participants’ intentions to receive the COVID-19 vaccine, and (3) compare participants’ knowledge assessment results with COVID-19 vaccine intentions. METHODS: A prospective, cross-sectional questionnaire was administered to patients participating in a pharmacist-led chronic disease state management program. The 22-item questionnaire assessed demographic information and evaluated the participant’s knowledge and vaccine intentions. Data were analyzed with an a priori alpha value of 0.05. RESULTS: Nearly all participants answered correctly on questions pertaining to COVID-19 infection (n = 92, 93%), COVID-19 symptoms (n = 96, 96%), and the Food and Drug Administration’s roles in vaccine approval processes (n = 92, 92%). Participants scored lower on questions involving the differing requirements between clinical trial phases (n = 20, 21%) and vaccine safety in the United States (n = 51, 53%). Most participants (n = 54, 55.1%) did not believe the trials were taking too long to produce a vaccine, but 40.4% of the participants (n = 40) believed the vaccine was approved too quickly. More than half of the participants (n = 55, 56.1%) desired more information on how vaccines get approved in the United States. Participants who scored higher on the knowledge assessment were more likely to have a plan to receive the vaccine (P = 0.008). CONCLUSIONS: The results of this study demonstrate the influence knowledge has on intentions to receive vaccines and may aid health care providers in their attempts to promote vaccinations. |
format | Online Article Text |
id | pubmed-8733284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Pharmacists Association®. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87332842022-01-06 Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization Carmosino, Elizabeth Ruisinger, Janelle F. Kinsey, Joshua Davis Melton, Brittany L. J Am Pharm Assoc (2003) Science and Practice BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowledge of vaccine approval processes relates to vaccination intentions. OBJECTIVES: The objectives of this study were to (1) evaluate participants’ knowledge regarding COVID-19 and vaccine approval processes, (2) evaluate participants’ intentions to receive the COVID-19 vaccine, and (3) compare participants’ knowledge assessment results with COVID-19 vaccine intentions. METHODS: A prospective, cross-sectional questionnaire was administered to patients participating in a pharmacist-led chronic disease state management program. The 22-item questionnaire assessed demographic information and evaluated the participant’s knowledge and vaccine intentions. Data were analyzed with an a priori alpha value of 0.05. RESULTS: Nearly all participants answered correctly on questions pertaining to COVID-19 infection (n = 92, 93%), COVID-19 symptoms (n = 96, 96%), and the Food and Drug Administration’s roles in vaccine approval processes (n = 92, 92%). Participants scored lower on questions involving the differing requirements between clinical trial phases (n = 20, 21%) and vaccine safety in the United States (n = 51, 53%). Most participants (n = 54, 55.1%) did not believe the trials were taking too long to produce a vaccine, but 40.4% of the participants (n = 40) believed the vaccine was approved too quickly. More than half of the participants (n = 55, 56.1%) desired more information on how vaccines get approved in the United States. Participants who scored higher on the knowledge assessment were more likely to have a plan to receive the vaccine (P = 0.008). CONCLUSIONS: The results of this study demonstrate the influence knowledge has on intentions to receive vaccines and may aid health care providers in their attempts to promote vaccinations. American Pharmacists Association®. Published by Elsevier Inc. 2022 2022-01-06 /pmc/articles/PMC8733284/ /pubmed/35065886 http://dx.doi.org/10.1016/j.japh.2022.01.001 Text en © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Science and Practice Carmosino, Elizabeth Ruisinger, Janelle F. Kinsey, Joshua Davis Melton, Brittany L. Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title | Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title_full | Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title_fullStr | Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title_full_unstemmed | Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title_short | Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization |
title_sort | vaccination approval literacy and its effects on intention to receive future covid-19 immunization |
topic | Science and Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733284/ https://www.ncbi.nlm.nih.gov/pubmed/35065886 http://dx.doi.org/10.1016/j.japh.2022.01.001 |
work_keys_str_mv | AT carmosinoelizabeth vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization AT ruisingerjanellef vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization AT kinseyjoshuadavis vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization AT meltonbrittanyl vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization |